The Massachusetts State Public Health Council recently unanimously passed regulations that implement a state law relating to a “Pharmaceutical and Medical Device Manufacturer Code of Conduct,” which imposes marketing restrictions on pharmaceutical and device companies. The statute and implementing regulations are intended to prevent undue influence by pharmaceutical and medical device companies on healthcare professionals and to increase the transparency of interactions between the groups. The Massachusetts regulations take effect on July 1, 2009. The first public reporting by companies of payments to healthcare professionals is due by July 1, 2010.
Click the link below to read the full alert.